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Abstract
Background: Disputes over authorship are increasing. This paper examines the options that researchers have in
resolving authorship disputes. Discussions about authorship disputes often address how to prevent disputes but
rarely address how to resolve them. Both individuals and larger research communities are harmed by the limited
options for dispute resolution.
Main body: When authorship disputes arise after publication, most existing guidelines recommend that the authors
work out the disputes between themselves. But this is unlikely to occur, because there are often large power
differentials between team members, and institutions (e.g., universities, funding agencies) are unlikely to have authority
over all team members. Other collaborative disciplines that deal with issues of collaborative creator credit could
provide models for scientific authorship. Arbitration or mediation could provide solutions to authorship disputes where
few presently exist. Because authors recognize journals’ authority to make decisions about manuscripts submitted to
the journal, journals are well placed to facilitate alternative dispute resolution processes.
Conclusion: Rather than viewing authorship disputes as rare events that must be handled on a case by case basis,
researchers and journals should view the potential for disputes as predictable, preventable, and soluble. Independent
bodies that can offer alternative dispute resolution services to scientific collaborators and/or journals could quickly help
research communities, particularly their most vulnerable members.
Keywords: Authorship, Alternative dispute resolution

Background
Academic authorship is an example of attribution [1],
where people’s career reputation is based on credit for
work they have performed. Many problems surrounding
attribution stem from one of two issues: when contributors cannot predict how credit will be given [1], and when
attribution is dictated by individuals with power [1]. Both
conditions are common in some research fields of academic publishing, contributing to the likelihood of authorship disputes.
There are no widely accepted criteria for what constitutes authorship [2–4]. Individual journals do not always
provide authorship guidelines [5, 6]. Researchers may
work under multiple authorship guidelines (e.g., funding
agency, institution [7], journal) that could conflict with
each other. Currently, the closest guidelines that approach
a widely accepted standard are recommendations for
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paper authorship in biomedicine from the International
Committee of Medical Journal Editors [8], also known as
the Vancouver guidelines. But even in biomedical research,
the field for which they were developed, some journals do
not describe the guidelines correctly [5], and many authors are ignorant of these guidelines [9–11] and/or disagree with them [10–12]. Because the Vancouver
guidelines are rarely followed by journals that purport to
abide by them [13–15], and were created from the top
down by journal editors, these guidelines are examples of
both “arbitrariness” and “power differential” factors that
contribute to attribution failures [1].
The Vancouver guidelines [8] only try to answer, “Who
should be an author?” They provide no guidance for other
contentious points regarding authorship, which increases
the possibility of authorship being assigned arbitrarily. For
multi-author papers, there are at least three designations
that are often viewed as more important than others: first
author, last author (also sometime called senior author),
and corresponding author [6, 7, 16–18], of which the last
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is the only author designation that the Vancouver guidelines address [8]. The first author is generally assumed to
be a person (often an early career researcher) who has
done the largest portion of the experimental work and the
writing, and who deserves most of the credit. The last author is generally assumed to be an individual (often in a
more advanced career stage) who is providing overarching
intellectual questions, funding, and writing, but has not
necessarily been directly involved in data collection. Some
research projects use last authorship as a proxy measure
for career stage [19, 20]. The author of one study described last authorship as, “the pinnacle of the research
career and has a lot of status that goes along with it” [21].
Authors between first and last are generally expected to
have made smaller contributions, listed in order of effort
(i.e., second author contributed more than third, etc.) [6].
The expectations of corresponding authorship vary but
the designation is often thought to indicate overall responsibility for the project [8, 18, 22]. Empirical research generally supports these interpretations [16], but in some
fields, author order is alphabetical and contains no information about contribution.
These practices mean that academic authorship is not
only a valuable resource; it can be a limited resource. That
some authorship designations are more valuable to career
advancement than others [19] increases the incentives for
people to game authorship systems and creates more reasons for disputes. The number of authors on journal articles has been increasing in many fields [16, 22–27]. The
current record-holder, in particle physics, is a paper with
5,154 authors [28], but biology papers have also cracked the
1,000 author mark [29]. As author lists have increased, the
problems of ascertaining and assigning credit by authorship
(or, if the paper is flawed, blame) [30] have increased, as
have the number of disputes over authorship [31].
People have used creative ways to spread the benefit of
receiving key authorship credits. An increasingly common
practice is to use author’s notes to designate equal contributions [32–34]. The record for greatest number of
“equally contributing” authors is unknown, but a cursory
search of recent issues of journals quickly found a paper
with seven authors (out of 44) listed as having made equal
contributions, and none were first author [35]. One article
with four authors designated that all contributed equally
(creating the linguistic puzzle of whether they should be
called “co-first” authors or “co-senior” authors), and listed
all as corresponding authors [36], making all three designations effectively meaningless. Journals have generally
not adopted policies or guidelines for equal contribution
statements [33], nor are there general practices for handling such notes in research evaluations [34]. Contribution
notes notwithstanding, the first author’s name becomes
the most associated with the paper because many journals's citations in the body of the text list only the first
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author when there are three or more, and “et al.” sweeps
away whatever information is conveyed by fine print about
equal contribution [2, 37–42].
The combination of many people (e.g., large research
teams) given vague guidance (e.g., authorship guidelines)
about distributing limited resources (e.g., first authorships)
with clear career consequences (e.g., hiring and promotion)
make authorship disputes a completely predictable outcome. Studies on the prevalence of authorship disputes
usually report somewhere between a third to two-thirds of
researchers have been involved in authorship disagreements [10, 43–46], but some of those may have been resolved before publication. It is difficult to know how many
projects have never been published because of unresolved
authorship disputes, although it is not zero [41]. Researchers not submitting papers because of disputes would
explain why journal editors do not think authorship disputes are a severe problem [47], with 29% of editors reporting authorship disputes never happen at their journal [47].
Many papers discuss the importance of dispute prevention, often mentioning the need for clear guidelines and
extensive communication about authorship expectations
between collaborators, mentors, and journals [5, 12, 31,
32, 37, 48–52]. But it is not reasonable to expect these
policies to prevent all problems [53]. The existence of
business contracts, for example, does not remove the possibility of lawsuits over failing to meet contractual obligations. There is less discussion of dispute resolution (but
see [54]), which is the focus of the remainder of this paper,
particularly disputes that are not resolved when a paper is
published. Papers are routinely retracted because of
authorship disputes [55], with one study showing authorship disputes contributed to 7.4% of retractions [56]. Reasons for retraction include author omission [57, 58] and
disagreements over author placement [59]. Because retractions represent serious sanctions and are rare (but increasing) [56, 60–63], retractions probably record only a
fraction of authorship disputes. There are many unanswered questions about how authorship disputes affect
research publications and career advancement.

Authorship disputes are difficult to resolve
Disputes can harm both the individuals involved and the
communities they belong to. Communities usually have
practices intended to prevent disputes before they occur
and resolve them if they do occur. Good policies and
guidelines can help prevent disputes or help parties involved resolve their own fights. Even with good policies,
however, disputes can still happen. People expect communities to have mechanisms to help resolve disputes
(e.g., policing, legal action, counseling). If two neighbors
fight, others in the community may hope they sort it out
themselves, and combatants might argue that only they
have the right to end the fight. But it would be unethical
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for no community member to ever get involved in the
fight, instead allowing the conflict to escalate until one
person was dead. Having no way of resolving disputes in
progress has corrosive effects on communities, particularly its most vulnerable members. Yet this is close to the
reality of the situation in research communities for
authorship disputes: researchers may struggle to find any
help in resolving disputes.
The Committee on Publication Ethics [37] recommends
that authorship disputes be resolved by the authors working out their differences on their own. There are many
problems with trying to resolve such disputes internally.
Power differentials contribute to attribution problems [1],
and there are huge power differential between trainees
and senior scientists. Senior faculty are most likely to be
bullies [64, 65], making the potential for senior researchers
to dictate authorship credit ripe for abuse [7, 65]. Some
argue that nobody besides those involved in a project
should ever be involved in an authorship decision because
it would curtail academic freedom [7]. But this position favors the powerful and disenfranchises the vulnerable.
Some evidence suggests that people who belong to underrepresented groups are more likely to be caught in disputes [31], and it seems likely such individuals are less
likely to have disputes resolved to their satisfaction.
Communities can and do limit the freedom of individuals
to resolve their own disputes if the level of potential harm
to participants is great enough, and loss of credit due to
authorship disputes may be a little recognized factor driving underrepresented individuals out of scientific careers.
There is no guarantee that internal discussion will resolve the problem, despite clear incentives to do so, because journals reject or retract papers with authorship
disputes [7, 66]. Retracting a paper because of an authorship dispute is a “scorched earth” solution where nobody
wins. None of the authors win, because nobody gains
credit for a retracted paper. Nor do readers win, since
there was no implication that the science was unsound.
Nor do funding agencies win, since their investment in
the research sees no returns in publications.
If internal discussion fails to resolve the issue, there
are no generally recognized avenues for authors to seek
help in resolving it. Some options discussed below might
exist for some authors, but there are no norms in the research community for dispute resolution.
A trainee might inform an institutional administrator,
like a department chair or college Dean, who oversees the
principal investigator of the project. But when faculty
from multiple departments or institutions are involved in
collaborative projects, it may not be clear who is the relevant administrator to discuss the dispute with [6]. Administrators may have no authority to act even if they are
willing to step into an authorship dispute. Similarly,
ombuds offices [31] or committees [7] at institutions
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could conceivably play a role, but not every institution has
such offices. Research compliance or research integrity offices [50] might be relevant if misconduct was involved,
but authorship disputes can arise that involve no misconduct. Because the standards for authorship placement are
vague, any administrator or office charged with ensuring
compliance might reasonably ask what standards the researchers are supposed to be complying with.
Authors might ask journal editors to resolve authorship
disputes. By submitting a manuscript to a journal, authors
implicitly recognize the editor’s authority to decide what
goes into a journal. Some suggest this is part of an editor’s
responsibility [18], and some editors find that authors are
responsive to requests to shorten author lists [50]. But it
seems unfair and unwise to expect editors to resolve
authorship disputes on their own [37]. Editors probably
do not have the local knowledge [37, 67] or resources to
investigate the facts of a dispute thoroughly. Resolving
authorship disputes would be a significant expansion of an
editor’s responsibilities: it should not be their job. Having
editors investigate disputes or make recommendations for
authorship would create opportunities for conflicts of
interest [68]. This is not to say that the editors and staff of
journals should have no role in dispute resolution, however, as will be discussed below.

Creator credits in other fields
There are many collaborative fields where attribution is
contentious [1] that might provide models for science. For
example, many popular comic characters were created by
teams of writers and artists, who were often denied any
credit for years [69]. Batman was first drawn by artist Bob
Kane, but writer Bill Finger wrote many stories that defined the character and never received credit until after
his death [70–72]. Spider-Man was sometimes credited as
the creation of writer Stan Lee, prompting pushback from
artists Jack Kirby [73, 74], who said he created the character, and Steve Ditko [75, 76], who said he co-created the
character (with Lee generally agreeing with Ditko [75,
76]). The question of who created these iconic pop culture
characters is more than a point of debate for comic book
historians. Like academic authorship, there are clear financial and career rewards associated with creator credits.
These characters earn huge amounts of money from
comics, licensing, film, and television, and creator credit
can ensure artists receive some of it. The financial stakes
involved has meant that creator credit has been the subject of lawsuits or other legal actions by writers, artists, or
their estates [69, 77]. Such legal action is hardly unique to
comics [78]. But using courts to resolve on authorship
credit on scientific papers is rare [54, 79]. The law is often
neutral on questions of authorship, which is exacerbated
by the lack of clarity about professional practices and ambiguous damages from denied authorship credit. Lawsuits
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are costly and lengthy [54]. In one case where an authorship dispute did go to court [79], the ruling favored the
plaintiff who claimed first authorship, but the manuscript
was apparently never published. No paper matching the
description can be found in databases of scientific publications. Like the old joke, “The surgery was a success, but
the patient died,” the plaintiff won the case, but science
lost.
Another collaborative field where there are routinely
credit disputes is screenwriting for television and movies
in the USA [1, 32]. There are similarities between
screenwriting and academic writing. First, both movie
scripts and scientific articles often pass through the
hands of many writers. Thirty-five people were involved
in writing in The Flintsones movie, but only three names
appeared on screen when the film was released [80].
Second, in both movie scripts and scientific articles,
credit is complex and cryptic to outsiders [81]. For example, the writing credits for the movie Lethal Weapon
3 read, “Screenplay by Jeffrey Boam and Jeffrey Boam &
Robert Mark Kamen. Story by Jeffrey Boam.” Details like
why Boam’s name is listed twice in the “Screenplay”
credit or why names are joined with “and” versus an ampersand are as baffling to people unfamiliar with screenwriting conventions as scholarly authorship is to people
outside academic fields. Unlike some of the cases with
comics, however, disputes over screen credits usually go
to arbitration rather than court. Usually, the Writer’s
Guild of America is the final arbiter [80, 81]. The
Writer’s Guild of America has established rules for determining who gets credit [82], albeit with room for interpretation, like what “substantial” means.

Alternative dispute resolution in academic
publishing
Mediation, arbitration, and combinations of these (e.g.,
med-arb [83, 84]) are examples of alternative dispute
resolution [68]. They are “alternative” in the sense they
are not resolved in courts. Alternative dispute resolution
could be a valuable means for resolving authorship disputes that bypasses litigation [54].
A major difference between screenwriting and science
is that Hollywood screenwriters are part of a single
unionized workforce [1], while scientists lack any such
central authority to compel them to seek arbitration or
mediation. In cases where all authors were at the same
institution, an institutional committee, or research ethics
consultants might provide mediation [7, 85]. But the
only authority that would be relevant to all authors of a
manuscript, regardless of institutional affiliation, is the
journal’s editorial staff. Authors implicitly recognize this
authority when they submit a manuscript. But as discussed above, implicit authority alone does not mean editors are well positioned to perform arbitration or
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mediation. Rather, arbitration or mediation should be
conducted not by editors, but by independent agencies
(e.g., committees, businesses, non-governmental organizations, research ethics consultants) that specialize in alternative dispute resolution. These organizations would
be staffed by people of diverse backgrounds who are experienced with scientific publishing, investigation, and
dispute resolution. These agencies might be operated by
a publisher, a journal, an institution, or a scientific society, but be independent from the editorial team, similar
to the ethics committees (e.g., [86]) or journalists working at scientific journals. Dispute resolution agencies
could provide services to many journals, not just one. In
this model, editors would facilitate a process of alternative dispute resolution, not conduct it.
The tacit recognition of editorial authority could be
made explicit. For example, when a journal accepts a
paper, the editors could require authors to sign a form
agreeing that by having this paper published in this journal, they would submit to binding arbitration if a dispute
arises. Many journals already have such processes in
place for copyright transference, payment of page
charges or open access fees, and so on. Mandated arbitration poses potential ethical problems [68], so journals
may not want to make arbitration a requirement for
publication. Instead, journals could recommend mediation or arbitration only if disputes arise. Authors voluntarily agreeing to arbitration or mediation does not
threaten academic freedom [7]. If the authors did not
agree to binding arbitration, or mediation fails, the authors would be free to try to resolve the problem internally within a set time or face an editor’s decision by fiat.
The key point is that “work it out by yourselves” becomes one of several options for authors in a dispute,
not the only option.
The simplest scenario is one in which a dispute arises
after a paper has been submitted to a journal. Depending
on the journal’s specific policy, journal staff would either
recommend mediation or arbitration, or simply initiate
the process by contacting the alternative dispute resolution agency. Because alternative dispute resolution
processes come in many forms [83, 84], journals might
differ in what dispute resolution process they prefer. For
papers that have already been published, however, some
form of resolution including arbitration might be more
appropriate than mediation alone because an editor
needs to make a decision about a paper’s version of record. The mediators or arbiters would investigate, applying the generally accepted practices of the field, which
would be known to authors in advance. For example, in
life sciences, it would be expected that the author who
performed the most tasks would be first author, and the
author with the greatest seniority would be last. While
authors may overvalue their own work [87], people
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engaged in dispute resolution in any field are routinely
tasked with making decisions where participants
give contradictory information (e.g., judges and juries in
court). A mediation or arbitration process might be similar
in some ways to a peer review system. There may be multiple mediators or arbiters who investigate the claims and
facts of the dispute, perhaps with some specifically assigned
to act as advocates for the different individuals, like prosecution and defense attorneys in court. The alternative dispute resolution committee or agency would deliver
recommendations to the journal’s editor-in-chief, who
would implement the decision.
Alternative dispute resolution could be supported by
funds from publishers and journals, as part of their commitment to ethical publishing practices [88]. Assistance in
resolving disputes could become a mark of excellence as a
service that high-quality journals are expected to offer, like
enlisting and coordinating the efforts of peer reviewers,
editing, typesetting, copyediting, and promotion of articles
to media. Funding agencies also have incentives to support
the costs of alternative dispute resolution. Authorship disputes diminishes the return on funders’ investments by
preventing publication of research they funded. Funding
agencies might make arbitration or mediation permissible
expenses for grants, like how many funding agencies
started including article processing charges as allowable
expenses for the agency to support open access publication. Alternately, funding agencies might set aside some
funds for dispute resolution as a contingency and provide
them to researchers on a case-by-case basis.
The description above focuses on dispute resolution
occurring after a manuscript has been submitted to a
journal. But alternative dispute resolution agencies could
also be involved in dispute prevention by providing services to authors directly. This would be similar to independent businesses that assist with writing and editing
(often for authors writing in languages that they are not
fluent in) [89], which are separate from the review, copyediting, and proofing services provided by journals.
Making alternative dispute resolution available to authors
through independent businesses may prevent disputes
from occurring or resolve them before manuscripts are
submitted to journals, which would prevent errata or retractions. Research proposals, particularly collaborations
between individuals at different institutions, could require
that principle investigators submit plans for dispute resolution [6, 90], analogous to requirements that proposals
include plans for data management. These plans could include dispute resolution services.
One advantage of alternative dispute resolution systems is that they increase transparency by providing a
clear pathway for dispute resolution. The increased presence of alternative dispute resolution on the publishing
landscape may encourage improved record-keeping,
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because clear documentation of the project’s progress
would be essential to having a decision in one’s favor.
The more authorship disputes go through arbitration or
mediation and are resolved through that process, the
more likely that authors will become aware of the need
to talk to each other about their expectations for authorship, much like how early fights by comic creators changed practices in that industry [91, 92].
The model for alternative dispute resolution for
authorship suggested here is similar to research ethics
consultation services [85, 93]. These consulting services
provide advice on topics that are not covered by regulatory agencies like institutional review boards (IRBs) [93],
potentially including dispute resolution [85]. One consulting service was funded jointly by research funding
agencies and a host institution [94], providing an example of how such agencies might be supported.
Creating alternative dispute resolution processes within
academia faces a common problem that individual interests are not always aligned with community interests.
People who now have the seniority to try to determine or
influence authorship credit could have that power reduced
if alternative dispute resolution services were well known
and readily available to authors. But because many academics have personally experienced authorship disputes,
they might see the value for the research community for
having new mechanisms for resolving disputes. Furthermore, because authorship disputes reduce scientific productivity, stakeholders who are concerned with maximizing
research outcomes (e.g., funding agencies) have incentives
to join community leaders on this issue in raising awareness and creating new policies.

Conclusion
Authorship disputes can be anticipated and ameliorated.
While more can be done to prevent authorship disputes,
the lack of options for resolving authorship disputes that
occur is a major ethical challenge that the research community needs to address. To borrow from the old saying,
an ounce of prevention may be better than a pound of
cure, but when it comes to authorship disputes, it seems
that currently, there are only ounces of prevention and no
cure in any quantity. Alternative dispute resolution that is
facilitated by journals’ staff but not necessarily run by
them could help address this problem.
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